Trends in Overall Survival in Lung Adenocarcinoma with EGFR Mutation, KRAS Mutation, or No Mutation.

Faehling M, Fallscheer S, Schwenk B, Seifarth H, Sträter J, Lengerke C, Christopoulos P

Open source

DOI
10.3390/cancers17071237
Published
2025 Apr 5
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers17071237,
  title = {Trends in Overall Survival in Lung Adenocarcinoma with EGFR Mutation, KRAS Mutation, or No Mutation.},
  author = {Faehling M and Fallscheer S and Schwenk B and Seifarth H and Sträter J and Lengerke C and Christopoulos P},
  year = {2025},
  journal = {Cancers},
  doi = {10.3390/cancers17071237},
  url = {https://doi.org/10.3390/cancers17071237}
}

RIS

TY  - JOUR
TI  - Trends in Overall Survival in Lung Adenocarcinoma with EGFR Mutation, KRAS Mutation, or No Mutation.
AU  - Faehling M
AU  - Fallscheer S
AU  - Schwenk B
AU  - Seifarth H
AU  - Sträter J
AU  - Lengerke C
AU  - Christopoulos P
PY  - 2025
JO  - Cancers
DO  - 10.3390/cancers17071237
UR  - https://doi.org/10.3390/cancers17071237
ER  - 

APA

M, F., S, F., B, S., H, S., J, S., C, L., & P, C. (2025). Trends in Overall Survival in Lung Adenocarcinoma with EGFR Mutation, KRAS Mutation, or No Mutation.. Cancers. https://doi.org/10.3390/cancers17071237

Source records